Silicon-substituted calcium phosphate (Si-CaP) is a promising bioactive material for bone tissue engineering. The mechanism of Si-CaP regulates osteogenic-angiogenic coupling during bone regeneration has not been fully elucidated. In this study, we screened the targets of Si-CaP and osteogenic-angiogenic coupling. 83 common genes were regarded as key targets for Si-CaP regulation of the osteogenic-angiogenic coupling. Then, we performed protein-protein interaction analysis, GO and KEGG enrichment analysis of these 83 targets to further predict their molecular mechanism. Our results showed that Si-CaP treatment could regulate the osteogenic-angiogenic coupling by up-regulating the expression of Toll-like receptor 4 (TLR4), and the phosphorylation of AKT which in turn activating the PI3K/AKT signaling pathway, promoting the expression of RUNX2, OPN, VEGF. In addition, we also found that TLR4 siRNA treatment could block the PI3K/AKT signaling pathway, while inhibiting the promoting effect of Si-CaP. However, although LY294002 can achieve the same inhibitory effect as TLR4 siRNA by blocking the PI3K/AKT signaling pathway, it could not affect the expression of TLR4. This indicates that TLR4 is an upstream activator of PI3K/AKT signaling pathway. These results are highly consistent with the prediction of bioinformatics. In conclusion, we have elucidated the role of TLR4/PI3K/AKT signaling axis in Si-CaP mediated osteogenic-angiogenic coupling for the first time. This study provides new data onto the regulatory role and molecular mechanism of Si-CaP in the process of osteogenic-angiogenic coupling, which strongly supports its wide application for bone tissue engineering.
SunCTianYXuW, et al.Development and performance analysis of Si-CaP/fine particulate bone powder combined grafts for bone regeneration. Biomed Eng Online2015; 14: 47.
2.
KirschnerHJObermayrFSchaeferJ, et al.Treatment of benign bone defects in children with silicate-substituted calcium phosphate (SiCaP). Eur J Pediatr Surg2012; 22(2): 143–147.
3.
PutzCWiedenhöferBGernerHJ, et al.Spinal fusion of an unstable atlantoaxial fracture in a completely tetraplegic patient using silicate-substituted calcium phosphate. Eur J Trauma Emerg Surg2010; 36(2): 169–175.
4.
HutchensSACampionCAssadM, et al.Efficacy of silicate-substituted calcium phosphate with enhanced strut porosity as a standalone bone graft substitute and autograft extender in an ovine distal femoral critical defect model. J Mater Sci Mater Med2016; 27(1): 20.
5.
TianYCuiLHXiangSY, et al.Osteoblast-oriented differentiation of BMSCs by co-culturing with composite scaffolds constructed using silicon-substituted calcium phosphate, autogenous fine particulate bone powder and alginate in vitro. Oncotarget2017; 8(51): 88308–88319.
6.
De GodoyRFHutchensSCampionC, et al.Silicate-substituted calcium phosphate with enhanced strut porosity stimulates osteogenic differentiation of human mesenchymal stem cells. J Mater Sci Mater Med2015; 26(1): 5387.
7.
CameronKTraversPChanderC, et al.Directed osteogenic differentiation of human mesenchymal stem/precursor cells on silicate substituted calcium phosphate. J Biomed Mater Res A2013; 101(1): 13–22.
8.
HingKAWilsonLFBucklandT. Comparative performance of three ceramic bone graft substitutes. Spine J2007; 7(4): 475–490.
9.
Costa-RodriguesJReisSCastroA, et al.Bone anabolic effects of soluble Si: in vitro studies with human mesenchymal stem cells and CD14+ osteoclast precursors. Stem Cells Int2016; 2016: 5653275.
10.
KimEJBuSYSungMK, et al.Effects of silicon on osteoblast activity and bone mineralization of MC3T3-E1 cells. Biol Trace Elem Res2013; 152(1): 105–112.
11.
JugdaohsinghRTuckerKLQiaoN, et al.Dietary silicon intake is positively associated with bone mineral density in men and premenopausal women of the Framingham offspring cohort. J Bone Miner Res2004; 19(2): 297–307.
12.
CarlisleEM. Silicon: an essential element for the chick. Science1972; 178(4061): 619–621.
13.
SchwarzKMilneDB. Growth-promoting effects of silicon in rats. Nature1972; 239(5371): 333–334.
14.
IlyasAVeltonMShahA, et al.Rapid regeneration of vascularized bone by nanofabricated amorphous Silicon Oxynitrophosphide (SiONP) overlays. J Biomed Nanotechnol2019; 15(6): 1241–1255.
15.
PietakAMReidJWStottMJ, et al.Silicon substitution in the calcium phosphate bioceramics. Biomaterials2007; 28(28): 4023–4032.
16.
MendeWGötzlRKuboY, et al.The role of adipose stem cells in bone regeneration and bone tissue engineering. Cells2021; 10(5): 975.
17.
DiomedeFMarconiGDFonticoliL, et al.Functional relationship between osteogenesis and angiogenesis in tissue regeneration. Int J Mol Sci2020; 21(9): 3242.
18.
TangZWuXHuL, et al.Circ-100290 positively regulates angiogenesis induced by conditioned medium of human amnion-derived mesenchymal stem cells through miR-449a/eNOS and miR-449a/VEGFA Axes. Int J Biol Sci2020; 16(12): 2131–2144.
19.
PizzicannellaJGugliandoloAOrsiniT, et al.Engineered extracellular vesicles from human periodontal-ligament stem cells increase VEGF/VEGFR2 expression during bone regeneration. Front Physiol2019; 10: 512.
20.
AnGZhangWBMaDK, et al.Influence of VEGF/BMP-2 on the proliferation and osteogenetic differentiation of rat bone mesenchymal stem cells on PLGA/gelatin composite scaffold. Eur Rev Med Pharmacol Sci2017; 21(10): 2316–2328.
21.
De MatteiMGrassilliSPellatiA, et al.Pulsed electromagnetic fields modulate miRNAs during osteogenic differentiation of bone mesenchymal stem cells: a possible role in the osteogenic-angiogenic coupling. Stem Cell Rev Rep2020; 16(5): 1005–1012.
22.
LeeSLiZMengD, et al.Effect of silicon-doped calcium phosphate cement on angiogenesis based on controlled macrophage polarization. Acta Biochim Biophys Sin (Shanghai)2021; 53(11): 1516–1526.
23.
LiuWJJiangZMChenY, et al.Network pharmacology approach to elucidate possible action mechanisms of Sinomenii Caulis for treating osteoporosis. J Ethnopharmacol2020; 257: 112871.
24.
ShannonPMarkielAOzierO, et al.Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res2003; 13(11): 2498–2504.
25.
SzklarczykDGableALLyonD, et al.STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res2019; 47(D1): D607–D613.
26.
ZhouYZhouBPacheL, et al.Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun2019; 10(1): 1523.
27.
NiuLDangCLiL, et al.Next-generation sequencing-based identification of EGFR and NOTCH2 complementary mutations in non-small cell lung cancer. Oncol Lett2021; 22(2): 594.
28.
GibsonIRBestSMBonfieldW. Chemical characterization of silicon-substituted hydroxyapatite. J Biomed Mater Res1999; 44(4): 422–428.
29.
LiuLLiuYFengC, et al.Lithium-containing biomaterials stimulate bone marrow stromal cell-derived exosomal miR-130a secretion to promote angiogenesis. Biomaterials2019; 192: 523–536.
30.
YeCZhangWHangK, et al.Extracellular IL-37 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells via activation of the PI3K/AKT signaling pathway. Cell Death Dis2019; 10(10): 753.
31.
HoriuchiSHiasaMYasueA, et al.Fabrications of zinc-releasing biocement combining zinc calcium phosphate to calcium phosphate cement. J Mech Behav Biomed Mater2014; 29: 151–160.
32.
JulienMKhairounILeGerosRZ, et al.Physico-chemical-mechanical and in vitro biological properties of calcium phosphate cements with doped amorphous calcium phosphates. Biomaterials2007; 28(6): 956–965.
33.
YuTYeJWangY, et al.Preparation and characterization of a novel strontium-containing calcium phosphate cement with the two-step hydration process. Acta Biomater2009; 5(7): 2717–2727.
34.
SayerMStratilatovADReidJ, et al.Structure and composition of silicon-stabilized tricalcium phosphate. Biomaterials2003; 24(3): 369–382.
35.
MotisukeMMestresGRenóCO, et al.Influence of Si substitution on the reactivity of α-tricalcium phosphate. Mater Sci Eng C Mater Biol Appl2017; 75: 816–821.
36.
GrinnellFFeldMK. Adsorption characteristics of plasma fibronectin in relationship to biological activity. J Biomed Mater Res1981; 15(3): 363–381.
37.
VandiverJDeanDPatelN, et al.Silicon addition to hydroxyapatite increases nanoscale electrostatic, van der Waals, and adhesive interactions. J Biomed Mater Res A2006; 78(2): 352–363.
38.
De AzaPNGarcía-BernalDCragnoliniF, et al.The effects of Ca2SiO4-Ca3(PO4)2 ceramics on adult human mesenchymal stem cell viability, adhesion, proliferation, differentiation and function. Mater Sci Eng C Mater Biol Appl2013; 33(7): 4009–4020.
39.
SillerIGEppingNMLavrentievaA, et al.Customizable 3D-printed (Co-)cultivation systems for in vitro study of angiogenesis. Materials (Basel)2020; 13(19): 4290.
40.
HingKARevellPASmithN, et al.Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds. Biomaterials2006; 27(29): 5014–5026.
41.
BalamuruganARebeloAHLemosAF, et al.Suitability evaluation of sol-gel derived Si-substituted hydroxyapatite for dental and maxillofacial applications through in vitro osteoblasts response. Dent Mater2008; 24(10): 1374–1380.
42.
Pevsner-FischerMMoradVCohen-SfadyM, et al.Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood2007; 109(4): 1422–1432.
43.
LiottaFAngeliRCosmiL, et al.Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells2008; 26(1): 279–289.
44.
ZhangMXueYChenH, et al.Resveratrol inhibits MMP3 and MMP9 expression and secretion by suppressing TLR4/NF-κB/STAT3 activation in Ox-LDL-Treated HUVECs. Oxid Med Cell Longev2019; 2019: 9013169.
45.
HeXWangHJinT, et al.TLR4 activation promotes Bbone marrow MSC proliferation and osteogenic differentiation via Wnt3a and Wnt5a signaling. PLoS One2016; 11(3): e0149876.
46.
RaicevicGNajarMPietersK, et al.Inflammation and toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin. Tissue Eng A2012; 18(13–14): 1410–1418.
47.
HuLZangMDWangHX, et al.Biglycan stimulates VEGF expression in endothelial cells by activating the TLR signaling pathway. Mol Oncol2016; 10(9): 1473–1484.
48.
LuYXingJYinX, et al.Bone marrow-derived CD44+ cells migrate to tissue-engineered constructs via SDF-1/CXCR4-JNK pathway and aid bone repair. Stem Cells Int2019; 2019: 1513526.
49.
LiXHuangCSuiCL, et al.Formononetin, J1 and J2 have different effects on endothelial cells via EWSAT1-TRAF6 and its downstream pathway. J Cell Mol Med2020; 24(1): 875–885.
50.
GaoLLiSLLiYK. Liraglutide promotes the osteogenic differentiation in MC3T3-E1 cells via regulating the expression of Smad2/3 through PI3K/Akt and Wnt/β-catenin pathways. DNA Cell Biol2018; 37(12): 1031–1043.
51.
ChenJZhangXLiuX, et al.Ginsenoside Rg1 promotes cerebral angiogenesis via the PI3K/Akt/mTOR signaling pathway in ischemic mice. Eur J Pharmacol2019; 856: 172418.
52.
LuoZShangXZhangH, et al.Notch signaling in osteogenesis, osteoclastogenesis, and angiogenesis. Am J Pathol2019; 189(8): 1495–1500.
53.
WangBXXuJJHuJ, et al.Effects of miR-153 on angiogenesis in MCAO rats through Shh signaling pathway. Eur Rev Med Pharmacol Sci2019; 23(2): 732–739.
LiuDWangXQinW, et al.Suppressive effect of exogenous carbon monoxide on endotoxin-stimulated platelet over-activation via the glycoprotein-mediated PI3K-Akt-GSK3β pathway. Sci Rep2016; 6: 23653.
56.
WenNGuoBZhengH, et al.Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway. Int J Oncol2019; 55(4): 879–895.
57.
SunYWuCMaJ, et al.Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signaling. Exp Cell Res2016; 347(2): 274–282.
58.
XuSWangJJiangJ, et al.TLR4 promotes microglial pyroptosis via lncRNA-F630028O10Rik by activating PI3K/AKT pathway after spinal cord injury. Cell Death Dis2020; 11(8): 693.
